Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Luminex Corporation    LMNX   US55027E1029

Delayed Quote. Delayed Nasdaq - 07/24 04:00:00 pm
17.1 USD   -3.50%
07/16 LUMINEX : Second Quarter Earnings Release Scheduled for July 28, 2014
07/14 LUMINEX : Sought by Health and Human Services
07/13 LUMINEX : Sets Second Quarter Results Release
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/18/2014 07/21/2014 07/22/2014 07/23/2014 07/24/2014 Date
17.11(c) 17.25(c) 17.43(c) 17.72(c) 17.1(c) Last
319 719 166 146 164 302 175 127 238 712 Volume
+3.20% +0.82% +1.04% +1.66% -3.50% Change
More quotes
Company
Luminex Corp. develops, manufactures and markets proprietary biological testing technologies and products with applications throughout the life sciences and diagnostics industries. It operates its business through two segments: Technology & Strategic Partnerships, and Assays & Related Products. The... 
Surperformance© rating of Luminex Corporation
Trading Rating : Investor Rating :
More about the company
Chart LUMINEX CORPORATION
Duration : Period :
Luminex Corporation Technical Analysis Chart | LMNX | US55027E1029 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 231 M
EBIT 2014 33,2 M
Net income 2014 20,2 M
Debt 2014 98,2 M
Yield 2014 -
Sales 2015 253 M
EBIT 2015 39,2 M
Net income 2015 24,5 M
Debt 2015 127 M
Yield 2015 -
PER 2014 34,20
PER 2015 26,51
EV / Sales 2014 3,57x
EV / Sales 2015 3,38x
Capitalization 727 M
More Financials
Latest news on LUMINEX CORPORATION
07/16 LUMINEX : Second Quarter Earnings Release Scheduled for July 28, 2014
07/14 LUMINEX : Sought by Health and Human Services
07/13 LUMINEX : Sets Second Quarter Results Release
07/10 LUMINEX : purchase order to Luminex for MicroPlex Microspheres
07/08 LUMINEX : Combined Synopsis/Solicitation - Notice of Intent to Sole Source- Lumi..
07/08 LUMINEX : Combine Solicitation - Notice of Intent to Sole Source- Luminex
07/07 LUMINEX : Second Quarter Earnings Release Scheduled for July 28, 2014
07/07 LUMINEX : Assigned Patent
07/03 LUMINEX : Combine Solicitation - Notice of Intent to Sole Source- Luminex
06/16 LUMINEX : Assigned Patent
06/11 LUMINEX : Special Notice - Luminex PH Salmonella Serotyping Assay Complete Kit
05/22 LABORATORY OF AMERICA : LabCorp Releases Luminex xTAG CYP2D6 Genotype Assay
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Technical analysis
Income Statement Evolution
Luminex Corporation : Income Statement Evolution
More Financials
EPS Revisions
Luminex Corporation : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF